Dokmak Safi, Paradis Valérie, Vilgrain Valérie, Sauvanet Alain, Farges Olivier, Valla Dominique, Bedossa Pierre, Belghiti Jacques
Department of HepatoBilioPancreatic Surgery, University of Paris 7 and Beaujon Hospital, Clichy, France.
Gastroenterology. 2009 Nov;137(5):1698-705. doi: 10.1053/j.gastro.2009.07.061. Epub 2009 Aug 5.
BACKGROUND & AIMS: Hepatocellular adenoma (HA) is associated with risk of bleeding and malignancy, justifying resection. Patients with multiple forms of HA are difficult to manage. We evaluated the characteristics and outcome of 122 patients with single and multiple HAs after surgery.
From 1990 to 2004, 122 patients (14 male) underwent surgical resection. Complications (hemorrhage and malignancy) were assessed according to size, number, and histologic subtype (steatotic, telangiectatic, and unclassified), with a mean follow-up period of 70 months.
Hemorrhagic HA occurred in 21% of cases and malignant HA occurred in 8%. Risk of complications was not related to the number of HAs but was associated with size (>5 cm), especially of telangiectatic and unclassified subtypes. Patients with steatotic HA had a low risk of complications. Malignant HA was more frequent in men (43%); all patients treated by partial resection survived, without recurrent malignancy, after a mean follow-up period of 78 months. After 109 patients with benign HA revealed recurrence or progression of HA in 8% and regression in 9% of cases. No complications were observed in 11 women who became pregnant during the follow-up period.
Patients with HAs greater than 5 cm, telangiectatic or unclassified subtypes, and men have an increased risk of complicated disease; resection should be restricted to these patients. The risk of complications was not related to the number of HAs, so patients with multiple HAs do not need liver transplantation.
肝细胞腺瘤(HA)有出血和恶变风险,因此有必要进行切除。多种形式HA的患者治疗起来较为困难。我们评估了122例单发和多发HA患者术后的特征及预后。
1990年至2004年,122例患者(14例男性)接受了手术切除。根据肿瘤大小、数量和组织学亚型(脂肪变性型、毛细血管扩张型和未分类型)评估并发症(出血和恶变)情况,平均随访期为70个月。
21%的病例发生出血性HA,8%的病例发生恶变HA。并发症风险与HA的数量无关,但与大小(>5 cm)有关,尤其是毛细血管扩张型和未分类型亚型。脂肪变性型HA患者并发症风险较低。恶变HA在男性中更常见(43%);所有接受部分切除术的患者在平均78个月的随访期后均存活,无恶变复发。109例良性HA患者中,8%出现HA复发或进展,9%病情缓解。随访期间11例怀孕女性未观察到并发症。
HA大于5 cm、毛细血管扩张型或未分类型亚型以及男性患者发生复杂疾病的风险增加;切除应限于这些患者。并发症风险与HA的数量无关,因此多发HA患者不需要肝移植。